158 related articles for article (PubMed ID: 33392508)
21. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
[TBL] [Abstract][Full Text] [Related]
22. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
Harrington BS; Kamdar R; Ning F; Korrapati S; Caminear MW; Hernandez LF; Butcher D; Edmondson EF; Traficante N; Hendley J; ; Gough M; Rogers R; Lourie R; Shetty J; Tran B; Elloumi F; Abdelmaksoud A; Nag ML; Mazan-Mamczarz K; House CD; Hooper JD; Annunziata CM
J Exp Clin Cancer Res; 2023 Oct; 42(1):270. PubMed ID: 37858159
[TBL] [Abstract][Full Text] [Related]
23. A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications.
Gobin M; Nazarov PV; Warta R; Timmer M; Reifenberger G; Felsberg J; Vallar L; Chalmers AJ; Herold-Mende CC; Goldbrunner R; Niclou SP; Van Dyck E
Cancer Res; 2019 Mar; 79(6):1226-1238. PubMed ID: 30674534
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer.
Kim SY; Choi KU; Hwang C; Lee HJ; Lee JH; Shin DH; Kim JY; Sol MY; Kim JH; Kim KH; Suh DS; Kwon BS
J Pathol Transl Med; 2019 Jul; 53(4):244-252. PubMed ID: 31316041
[TBL] [Abstract][Full Text] [Related]
25. Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.
Malkomes P; Lunger I; Luetticke A; Oppermann E; Haetscher N; Serve H; Holzer K; Bechstein WO; Rieger MA
Ann Surg Oncol; 2016 Sep; 23(9):2849-57. PubMed ID: 27059026
[TBL] [Abstract][Full Text] [Related]
26. High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
Emori M; Tsukahara T; Murase M; Kano M; Murata K; Takahashi A; Kubo T; Asanuma H; Yasuda K; Kochin V; Kaya M; Nagoya S; Nishio J; Iwasaki H; Sonoda T; Hasegawa T; Torigoe T; Wada T; Yamashita T; Sato N
PLoS One; 2013; 8(12):e84187. PubMed ID: 24376795
[TBL] [Abstract][Full Text] [Related]
27. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.
Mancuso P; Calleri A; Gregato G; Labanca V; Quarna J; Antoniotti P; Cuppini L; Finocchiaro G; Eoli M; Rosti V; Bertolini F
PLoS One; 2014; 9(12):e114713. PubMed ID: 25506915
[TBL] [Abstract][Full Text] [Related]
28. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M
J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050
[TBL] [Abstract][Full Text] [Related]
29. DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy.
Peiffer DS; Wyatt D; Zlobin A; Piracha A; Ng J; Dingwall AK; Albain KS; Osipo C
Cancer Res; 2019 Oct; 79(19):4965-4977. PubMed ID: 31387918
[TBL] [Abstract][Full Text] [Related]
30. Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma.
Taylor JT; Ellison S; Pandele A; Wood S; Nathan E; Forte G; Parker H; Zindy E; Elvin M; Dickson A; Williams KJ; Karabatsou K; McCabe M; McBain C; Bigger BW
Neuro Oncol; 2020 Sep; 22(9):1289-1301. PubMed ID: 32227096
[TBL] [Abstract][Full Text] [Related]
31. All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma.
Wang S; Liu J; Wu H; Jiang A; Zhao K; Yan K; Wu W; Han H; Zhang Y; Yang W
Chin J Cancer Res; 2021 Dec; 33(6):694-707. PubMed ID: 35125813
[TBL] [Abstract][Full Text] [Related]
32. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
33. Small nucleolar RNA signatures of lung tumor-initiating cells.
Mannoor K; Shen J; Liao J; Liu Z; Jiang F
Mol Cancer; 2014 May; 13():104. PubMed ID: 24886050
[TBL] [Abstract][Full Text] [Related]
34. Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence.
Andrieux G; Das T; Griffin M; Straehle J; Paine SML; Beck J; Boerries M; Heiland DH; Smith SJ; Rahman R; Chakraborty S
Genome Med; 2023 Jul; 15(1):48. PubMed ID: 37434262
[TBL] [Abstract][Full Text] [Related]
35. Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
Barone A; Sengupta R; Warrington NM; Smith E; Wen PY; Brekken RA; Romagnoli B; Douglas G; Chevalier E; Bauer MP; Dembowsky K; Piwnica-Worms D; Rubin JB
Oncotarget; 2014 Oct; 5(20):9811-22. PubMed ID: 25238146
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma.
Kim EL; Sorokin M; Kantelhardt SR; Kalasauskas D; Sprang B; Fauss J; Ringel F; Garazha A; Albert E; Gaifullin N; Hartmann C; Naumann N; Bikar SE; Giese A; Buzdin A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32102350
[No Abstract] [Full Text] [Related]
37. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.
Son MJ; Woolard K; Nam DH; Lee J; Fine HA
Cell Stem Cell; 2009 May; 4(5):440-52. PubMed ID: 19427293
[TBL] [Abstract][Full Text] [Related]
38. Prominin 1/CD133 endothelium sustains growth of proneural glioma.
Ding BS; James D; Iyer R; Falciatori I; Hambardzumyan D; Wang S; Butler JM; Rabbany SY; Hormigo A
PLoS One; 2013; 8(4):e62150. PubMed ID: 23637986
[TBL] [Abstract][Full Text] [Related]
39. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
